GPC3 and gastric cancer: Furthermore, in a study of 32 cases of AFP-producing gastric cancer, only 16% were positive for diffuse staining (50% or more of tumor cells) in AFP, whereas it was as high as 56% positive for glypican-3 and 78% for SALL4 [11].